Important Safety Information

The Omnipod® Insulin Management System is intended for subcutaneous delivery of insulin at set and variable rates for the management of diabetes mellitus in persons requiring insulin and for the quantitative measurement of glucose in fresh whole capillary blood from the finger. The glucose measurements should not be used for the diagnosis or screening for diabetes. The Personal Diabetes Manager (PDM) glucose meter is intended for single-patient use and should not be shared. The Omnipod® System has been tested and found to be safe for use with the following U-100 insulin: NovoRapid®, Humalog®, Apidra® or Admelog®. Refer to the Omnipod® Insulin Management System User Guide at omnipod.ca for complete safety information including indications, contraindications, warnings, cautions, and instructions. 

The Omnipod DASH® Insulin Management System is intended for subcutaneous (below the skin) delivery of insulin at set and variable rates to control blood glucose levels in persons with diabetes mellitus who require insulin.  Additionally, the Omnipod DASH® System permits manual entry of readings from blood glucose metres, enabling storage and display of blood glucose measurements. The Omnipod DASH® System has been tested and found to be safe for use with the following: NovoRapid® (insulin aspart), Fiasp® (insulin aspart), Humalog® (insulin lispro), Admelog® (insulin lispro), and Apidra® (insulin glulisine). Refer to the Omnipod DASH® Insulin Management System User Guide for complete safety information including indications, contraindications, warnings, cautions, and instructions.